The exact selection
The Weleda UK page identifies Baby Calendula Intensive Body Cream 75 ml, productg009654, with£9.95 including tax. The selected cream is distinct from the Calendula Body Lotion 200 ml, Face Cream 50 ml and Nappy Change Cream. A shared calendula range does not establish identical ingredients or use restrictions.
Ingredient fields matter
The current maker list includes sesame oil, lanolin, alcohol denat., hydrolyzed beeswax, calendula extract and Parfum, plus named fragrance constituents. The page’s no-synthetic-fragrance wording is therefore not a fragrance-free statement. The site does not classify this formula as universally safe, nut-free or vegan.
The actual age and scope wording
The maker says suitable from the first day. It also places a condition on nappy-area use concerning skin prone to rash. These statements remain maker wording, not a treatment instruction or an individual newborn recommendation. The shopping site does not choose where or how often a child should receive a product.
A practical comparison
The older Weleda catalogue contains a£9.75 price for this cream, while the current UK product page shows£9.95 including tax. The current page is the dated purchasing reference; the older catalogue is version history. Do not use the older ticket as a current discount, or attach the body lotion’s ingredients and 200 ml quantity to the 75 ml intensive cream.
Before choosing a package
A 75 ml quantity is a volume field, despite the word cream. Do not relabel it 75 g. For two selected packages, the declared total is 150 ml across two tubes. Confirm the actual new-packaging label because the maker explicitly notes that web ingredients and supplied labelling can differ.
Sources & scope
Checked November 5, 2026. Manufacturer and retailer references support the specific statements. Dated displayed prices are not final checkout quotes, performance rankings or performance testing. This shopping reference does not replace the exact product label or retailer instructions. Current received labels and independent paediatric/clinical/material/content/commerce review remain pending.